MUPIROCIN OINTMENT

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX25D8022 to Cardinal Health, Inc. (CAGE 00E55) for the delivery of 10 tubes of Mupirocin Ointment (NSN 6505014805678) at a total value of $56.70, with an award date of July 15, 2026. The order, identified as SPE2D926F7346, is a one-time firm delivery with FOB Destination terms, meaning the contractor bears all transportation costs and risk of loss until delivery at the USS KINGSVILLE LCS 36, via FPO AP 96694. Shipment must use traceable methods, and parcel post is strictly prohibited. The product is identified by multiple NDCs: 00093-1010-42, 45802-0112-22, and 51672-1312-00, and must be marked with the base contract number SPE2DX-25-D-8022 and the delivery order number SPE2D9-26-F-7346 using block printing for traceability. Acceptance occurs at the destination point by an authorized government representative, with no explicit quality standards beyond compliance with contract requirements. Payment will be processed electronically by the Defense Finance and Accounting Service in Columbus, OH, under appropriation code 97X4930 5CBX 001 2620 S33189, and invoicing is conducted through electronic voucher systems. Cardinal Health, Inc. has affirmed its status as a small business, small disadvantaged business, and women-owned small business, triggering potential reporting obligations under federal socioeconomic programs. The contracting officer is Lisa Quinn, who also serves as the acceptance authority, with Michelle Pampel as the issuing office contact. No specific clause text, MIL-STD references, special requirements, or evaluation factors are included in the delivery order documentation, indicating reliance on the underlying basic contract for terms and conditions, and suggesting a streamlined, low-value procurement executed under standard DLA supply chain protocols.